{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:55:30Z","timestamp":1772794530718,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00198-010-1201-x","type":"journal-article","created":{"date-parts":[[2010,3,31]],"date-time":"2010-03-31T11:32:46Z","timestamp":1270035166000},"page":"305-315","source":"Crossref","is-referenced-by-count":16,"title":["An observational study of glucocorticoid-induced osteoporosis prophylaxis in a national cohort of male veterans with rheumatoid arthritis"],"prefix":"10.1007","volume":"22","author":[{"given":"L.","family":"Caplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. E.","family":"Hines","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"Prochazka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. G.","family":"Saag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,1]]},"reference":[{"key":"1201_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jbmr.5650100202","volume":"10","author":"LJ Melton III","year":"1995","unstructured":"Melton LJ III (1995) How many women have osteoporosis now? J Bone Miner Res 10:175\u2013177","journal-title":"J Bone Miner Res"},{"key":"1201_CR2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","volume":"93","author":"TP Staa Van","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C (2000) Use of oral corticosteroids in the United Kingdom. QJM 93:105\u2013111","journal-title":"QJM"},{"key":"1201_CR3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","volume":"15","author":"TP Staa Van","year":"2000","unstructured":"Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993\u20131000","journal-title":"J Bone Miner Res"},{"key":"1201_CR4","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","volume":"44","author":"American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis","year":"2001","unstructured":"American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 44:1496\u20131503","journal-title":"Arthritis Rheum"},{"key":"1201_CR5","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1001\/archinte.163.21.2619","volume":"163","author":"RA Adler","year":"2003","unstructured":"Adler RA, Hochberg MC (2003) Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs. Arch Intern Med 163:2619\u20132624","journal-title":"Arch Intern Med"},{"key":"1201_CR6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11926-007-0026-x","volume":"9","author":"JE Compston","year":"2007","unstructured":"Compston JE (2007) Emerging consensus on prevention and treatment of glucocorticoid-induced osteoporosis. Curr Rheumatol Rep 9:78\u201384","journal-title":"Curr Rheumatol Rep"},{"key":"1201_CR7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0049-0172(00)80011-6","volume":"29","author":"JD Adachi","year":"2000","unstructured":"Adachi JD, Olszynski WP, Hanley DA, Hodsman AB, Kendler DL, Siminoski KG, Brown J, Cowden EA, Goltzman D, Ioannidis G, Josse RG, Ste-Marie LG, Tenenhouse AM, Davison KS, Blocka KL, Pollock AP, Sibley J (2000) Management of corticosteroid-induced osteoporosis. Semin Arthritis Rheum 29:228\u2013251","journal-title":"Semin Arthritis Rheum"},{"key":"1201_CR8","first-page":"793","volume":"30","author":"PN Sambrook","year":"2001","unstructured":"Sambrook PN, Diamond T, Ferris L, Fiatarone-Singh M, Flicker L, MacLennan A, Nowson C, O\u2019Neill S, Greville H (2001) Corticosteroid induced osteoporosis. Guidelines for treatment. Aust Fam Physician 30:793\u2013796","journal-title":"Aust Fam Physician"},{"key":"1201_CR9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00774-004-0596-x","volume":"23","author":"H Nawata","year":"2005","unstructured":"Nawata H, Soen S, Takayanagi R, Tanaka I, Takaoka K, Fukunaga M, Matsumoto T, Suzuki Y, Tanaka H, Fujiwara S, Miki T, Sagawa A, Nishizawa Y, Seino Y (2005) Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004). J Bone Miner Metab 23:105\u2013109","journal-title":"J Bone Miner Metab"},{"key":"1201_CR10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00198-005-2032-z","volume":"17","author":"JP Devogelaer","year":"2006","unstructured":"Devogelaer JP, Goemaere S, Boonen S, Body JJ, Kaufman JM, Reginster JY, Rozenberg S, Boutsen Y (2006) Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int 17:8\u201319","journal-title":"Osteoporos Int"},{"key":"1201_CR11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2753.2006.00647.x","volume":"12","author":"PP Geusens","year":"2006","unstructured":"Geusens PP, Lems WF, Verhaar HJ, Leusink G, Goemaere S, Zmierczack H, Compston J (2006) Review and evaluation of the Dutch guidelines for osteoporosis. J Eval Clin Pract 12:539\u2013548","journal-title":"J Eval Clin Pract"},{"key":"1201_CR12","first-page":"597","volume":"7","author":"B Ettinger","year":"2001","unstructured":"Ettinger B, Chidambaran P, Pressman A (2001) Prevalence and determinants of osteoporosis drug prescription among patients with high exposure to glucocorticoid drugs. Am J Manag Care 7:597\u2013605","journal-title":"Am J Manag Care"},{"key":"1201_CR13","first-page":"2195","volume":"25","author":"LM Buckley","year":"1998","unstructured":"Buckley LM, Marquez M, Hudson JO, Downs RW, Vacek P, Small RE, Poses R (1998) Variations in physicians\u2019 judgments about corticosteroid induced osteoporosis by physician specialty. J Rheumatol 25:2195\u20132202","journal-title":"J Rheumatol"},{"key":"1201_CR14","first-page":"1651","volume":"33","author":"KG Saag","year":"2006","unstructured":"Saag KG, Gehlbach SH, Curtis JR, Youket TE, Worley K, Lange JL (2006) Trends in prevention of glucocorticoid-induced osteoporosis. J Rheumatol 33:1651\u20131657","journal-title":"J Rheumatol"},{"key":"1201_CR15","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.10613","volume":"46","author":"DH Solomon","year":"2002","unstructured":"Solomon DH, Katz JN, Jacobs JP, La Tourette AM, Coblyn J (2002) Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice. Arthritis Rheum 46:3136\u20133142","journal-title":"Arthritis Rheum"},{"key":"1201_CR16","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1345\/1542-6270(2000)034<1380:MOGIOI>2.0.CO;2","volume":"34","author":"ME Elliott","year":"2000","unstructured":"Elliott ME, Farrah RM, Binkley NC, Carnes ML, Gudmundsson A (2000) Management of glucocorticoid-induced osteoporosis in male veterans. Ann Pharmacother 34:1380\u20131384","journal-title":"Ann Pharmacother"},{"key":"1201_CR17","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1007\/s00198-005-2016-z","volume":"16","author":"AC Feldstein","year":"2005","unstructured":"Feldstein AC, Elmer PJ, Nichols GA, Herson M (2005) Practice patterns in patients at risk for glucocorticoid-induced osteoporosis. Osteoporos Int 16:2168\u20132174","journal-title":"Osteoporos Int"},{"key":"1201_CR18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.20403","volume":"51","author":"DH Solomon","year":"2004","unstructured":"Solomon DH, Katz JN, La Tourette AM, Coblyn JS (2004) Multifaceted intervention to improve rheumatologists\u2019 management of glucocorticoid-induced osteoporosis: a randomized controlled trial. Arthritis Rheum 51:383\u2013387","journal-title":"Arthritis Rheum"},{"key":"1201_CR19","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/archinte.167.6.591","volume":"167","author":"JR Curtis","year":"2007","unstructured":"Curtis JR, Westfall AO, Allison J, Becker A, Melton ME, Freeman A, Kiefe CI, MacArthur M, Ockershausen T, Stewart E, Weissman N, Saag KG (2007) Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial. Arch Intern Med 167:591\u2013596","journal-title":"Arch Intern Med"},{"key":"1201_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.18553\/jmcp.2008.14.3.281","volume":"14","author":"MM Chitre","year":"2008","unstructured":"Chitre MM, Hayes W (2008) 3-year results of a member and physician intervention to reduce risk associated with glucocorticoid-induced osteoporosis in a health plan. J Manag Care Pharm 14:281\u2013290","journal-title":"J Manag Care Pharm"},{"key":"1201_CR21","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0002-9343(99)00265-X","volume":"107","author":"EM Aagaard","year":"1999","unstructured":"Aagaard EM, Lin P, Modin GW, Lane NE (1999) Prevention of glucocorticoid-induced osteoporosis: provider practice at an urban county hospital. Am J Med 107:456\u2013460","journal-title":"Am J Med"},{"key":"1201_CR22","first-page":"1298","volume":"28","author":"A Mudano","year":"2001","unstructured":"Mudano A, Allison J, Hill J, Rothermel T, Saag K (2001) Variations in glucocorticoid induced osteoporosis prevention in a managed care cohort. J Rheumatol 28:1298\u20131305","journal-title":"J Rheumatol"},{"key":"1201_CR23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00198-007-0345-9","volume":"18","author":"M Duyvendak","year":"2007","unstructured":"Duyvendak M, Naunton M, Atthobari J, van den Berg PB, Brouwers JR (2007) Corticosteroid-induced osteoporosis prevention: longitudinal practice patterns in The Netherlands 2001-2005. Osteoporos Int 18:1429\u20131433","journal-title":"Osteoporos Int"},{"key":"1201_CR24","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/art.20827","volume":"51","author":"JA Singh","year":"2004","unstructured":"Singh JA, Holmgren AR, Noorbaloochi S (2004) Accuracy of veterans Administration databases for a diagnosis of rheumatoid arthritis. Arthritis Rheum 51:952\u2013957","journal-title":"Arthritis Rheum"},{"key":"1201_CR25","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00198-006-0136-8","volume":"17","author":"JR Curtis","year":"2006","unstructured":"Curtis JR, Westfall AO, Allison JJ, Freeman A, Saag KG (2006) Channeling and adherence with alendronate and risedronate among chronic glucocorticoid users. Osteoporos Int 17:1268\u20131274","journal-title":"Osteoporos Int"},{"key":"1201_CR26","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200084","volume":"13","author":"TP Staa Van","year":"2002","unstructured":"Van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777\u2013787","journal-title":"Osteoporos Int"},{"key":"1201_CR27","volume-title":"Screening men for osteoporosis: who & how","author":"P Shekelle","year":"2007","unstructured":"Shekelle P, Munjas B, Liu H, Paige N, Zhou A (2007) Screening men for osteoporosis: who & how. Department of Veterans Affairs (HSR&D Evidence Synthesis Pilot Program), Washington, DC"},{"key":"1201_CR28","first-page":"609","volume-title":"Endocrinology & metabolism","author":"G Chrousos","year":"2001","unstructured":"Chrousos GP (2001) Glucocorticoid therapy. In: Felig P, Frohman L (eds) Endocrinology and metabolism, 4th edn, Chap 14. McGraw-Hill, New York, pp 609\u2013632","edition":"4"},{"key":"1201_CR29","first-page":"870","volume":"32","author":"TR Mikuls","year":"2005","unstructured":"Mikuls TR, Saag KG, George V, Mudano AS, Banerjee S (2005) Racial disparities in the receipt of osteoporosis related healthcare among community-dwelling older women with arthritis and previous fracture. J Rheumatol 32:870\u2013875","journal-title":"J Rheumatol"},{"key":"1201_CR30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.rhu.0000242778.65766.22","volume":"12","author":"LM Cruse","year":"2006","unstructured":"Cruse LM, Valeriano J, Vasey FB, Carter JD (2006) Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men. J Clin Rheumatol 12:221\u2013225","journal-title":"J Clin Rheumatol"},{"key":"1201_CR31","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/aje\/154.9.854","volume":"154","author":"S Schneeweiss","year":"2001","unstructured":"Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ (2001) Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154:854\u2013864","journal-title":"Am J Epidemiol"},{"key":"1201_CR32","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/1475-6773.00165","volume":"38","author":"S Schneeweiss","year":"2003","unstructured":"Schneeweiss S, Wang PS, Avorn J, Glynn RJ (2003) Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res 38:1103\u20131120","journal-title":"Health Serv Res"},{"key":"1201_CR33","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00198-004-1675-5","volume":"15","author":"V Elliot-Gibson","year":"2004","unstructured":"Elliot-Gibson V, Bogoch ER, Jamal SA, Beaton DE (2004) Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 15:767\u2013778","journal-title":"Osteoporos Int"},{"key":"1201_CR34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/PL00004174","volume":"11","author":"AM Tromp","year":"2000","unstructured":"Tromp AM, Ooms ME, Popp-Snijders C, Roos JC, Lips P (2000) Predictors of fractures in elderly women. Osteoporos Int 11:134\u2013140","journal-title":"Osteoporos Int"},{"key":"1201_CR35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00198-006-0185-z","volume":"18","author":"SJ Petty","year":"2007","unstructured":"Petty SJ, O\u2019Brien TJ, Wark JD (2007) Anti-epileptic medication and bone health. Osteoporos Int 18:129\u2013142","journal-title":"Osteoporos Int"},{"key":"1201_CR36","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archinte.162.3.338","volume":"162","author":"MC Sheppard","year":"2002","unstructured":"Sheppard MC, Holder R, Franklyn JA (2002) Levothyroxine treatment and occurrence of fracture of the hip. Arch Intern Med 162:338\u2013343","journal-title":"Arch Intern Med"},{"key":"1201_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-007-0449-2","volume":"19","author":"B Mezuk","year":"2008","unstructured":"Mezuk B, Eaton WW, Golden SH (2008) Depression and osteoporosis: epidemiology and potential mediating pathways. Osteoporos Int 19:1\u201312","journal-title":"Osteoporos Int"},{"key":"1201_CR38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P (2007) Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2013a meta-analysis. Osteoporos Int 18:427\u2013444","journal-title":"Osteoporos Int"},{"key":"1201_CR39","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1200\/JCO.2008.18.4184","volume":"26","author":"F Saad","year":"2008","unstructured":"Saad F, Adachi JD, Brown JP, Canning LA, Gelmon KA, Josse RG, Pritchard KI (2008) Cancer treatment-induced bone loss in breast and prostate cancer. J Clin Oncol 26:5465\u20135476","journal-title":"J Clin Oncol"},{"key":"1201_CR40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1359\/JBMR.041131","volume":"20","author":"LJ Melton III","year":"2005","unstructured":"Melton LJ III, Kyle RA, Achenbach SJ, Oberg AL, Rajkumar SV (2005) Fracture risk with multiple myeloma: a population-based study. J Bone Miner Res 20:487\u2013493","journal-title":"J Bone Miner Res"},{"key":"1201_CR41","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.amjmed.2007.12.012","volume":"121","author":"KM Berg","year":"2008","unstructured":"Berg KM, Kunins HV, Jackson JL, Nahvi S, Chaudhry A, Harris KA Jr, Malik R, Arnsten JH (2008) Association between alcohol consumption and both osteoporotic fracture and bone density. Am J Med 121:406\u2013418","journal-title":"Am J Med"},{"key":"1201_CR42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1053\/j.ajkd.2003.12.004","volume":"43","author":"J Cunningham","year":"2004","unstructured":"Cunningham J, Sprague SM, Cannata-Andia J, Coco M, Cohen-Solal M, Fitzpatrick L, Goltzmann D, Lafage-Proust MH, Leonard M, Ott S, Rodriguez M, Stehman-Breen C, Stern P, Weisinger J (2004) Osteoporosis in chronic kidney disease. Am J Kidney Dis 43:566\u2013571","journal-title":"Am J Kidney Dis"},{"key":"1201_CR43","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1525-139X.2007.00319.x","volume":"20","author":"A Gal-Moscovici","year":"2007","unstructured":"Gal-Moscovici A, Sprague SM (2007) Osteoporosis and chronic kidney disease. Semin Dial 20:423\u2013430","journal-title":"Semin Dial"},{"key":"1201_CR44","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/j.1572-0241.2000.02269.x","volume":"95","author":"C Trautwein","year":"2000","unstructured":"Trautwein C, Possienke M, Schlitt HJ, Boker KH, Horn R, Raab R, Manns MP, Brabant G (2000) Bone density and metabolism in patients with viral hepatitis and cholestatic liver diseases before and after liver transplantation. Am J Gastroenterol 95:2343\u20132351","journal-title":"Am J Gastroenterol"},{"key":"1201_CR45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00774-007-0833-1","volume":"26","author":"A Mounach","year":"2008","unstructured":"Mounach A, Ouzzif Z, Wariaghli G, Achemlal L, Benbaghdadi I, Aouragh A, Bezza A, El MA (2008) Primary biliary cirrhosis and osteoporosis: a case-control study. J Bone Miner Metab 26:379\u2013384","journal-title":"J Bone Miner Metab"},{"key":"1201_CR46","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/pds.1068","volume":"14","author":"S Perreault","year":"2005","unstructured":"Perreault S, Dragomir A, Desgagne A, Blais L, Rossignol M, Blouin J, Moride Y, Ste-Marie LG, Fernandes JC (2005) Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiol Drug Saf 14:685\u2013695","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1201_CR47","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","volume":"282","author":"MD Cabana","year":"1999","unstructured":"Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR (1999) Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement. JAMA 282:1458\u20131465","journal-title":"JAMA"},{"key":"1201_CR48","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejim.2007.06.030","volume":"19","author":"A Alexopoulou","year":"2008","unstructured":"Alexopoulou A, Dourakis SP, Mantzoukis D, Pitsariotis T, Kandyli A, Deutsch M, Archimandritis AJ (2008) Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med 19:505\u2013510","journal-title":"Eur J Intern Med"},{"key":"1201_CR49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.archger.2007.06.007","volume":"47","author":"HL Liao","year":"2008","unstructured":"Liao HL, Chen JT, Ma TC, Chang YS (2008) Analysis of drug-drug interactions (DDIs) in nursing homes in Central Taiwan. Arch Gerontol Geriatr 47:99\u2013107","journal-title":"Arch Gerontol Geriatr"},{"key":"1201_CR50","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jclinepi.2004.03.002","volume":"57","author":"AJ Perkins","year":"2004","unstructured":"Perkins AJ, Kroenke K, Unutzer J, Katon W, Williams JW, Hope C, Callahan CM (2004) Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol 57:1040\u20131048","journal-title":"J Clin Epidemiol"},{"key":"1201_CR51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/ajhp\/61.3.267","volume":"61","author":"JT Lurk","year":"2004","unstructured":"Lurk JT, DeJong DJ, Woods TM, Knell ME, Carroll CA (2004) Effects of changes in patient cost sharing and drug sample policies on prescription drug costs and utilization in a safety-net-provider setting. Am J Health Syst Pharm 61:267\u2013272","journal-title":"Am J Health Syst Pharm"},{"key":"1201_CR52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.healthpol.2006.11.002","volume":"82","author":"X Li","year":"2007","unstructured":"Li X, Guh D, Lacaille D, Esdaile J, Anis AH (2007) The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities. Health Policy 82:340\u2013347","journal-title":"Health Policy"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1201-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-010-1201-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1201-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T11:08:20Z","timestamp":1635160100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-010-1201-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,1]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1007\/s00198-010-1201-x","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,1]]}}}